Literature DB >> 20087628

Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).

M Raithel1, A Nägel, Y Zopf, Th deRossi, Ch Stengel, A Hagel, J Kressel, E G Hahn, P Konturek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20087628     DOI： 10.1007/s00011-009-0120-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  7 in total

1.  Evaluation of urinary N-methylhistamine excretion during a long-term follow up of patients with inactive Crohn's disease.

Authors:  S Kimpel; A Nägel; C Kestler; B Backhaus; S Straube; F Buchwald; H W Schultis; J Kressel; E G Hahn; M Raithel
Journal:  Inflamm Res       Date:  2007-04       Impact factor: 4.575

Review 2.  Antiallergic effects of H1-receptor antagonists.

Authors:  F M Baroody; R M Naclerio
Journal:  Allergy       Date:  2000       Impact factor: 13.146

3.  The jejunal secretion of histamine is increased in active Crohn's disease.

Authors:  L Knutson; O Ahrenstedt; B Odlind; R Hällgren
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

4.  Ketotifen therapy for acute ulcerative colitis in children: a pilot study.

Authors:  N L Jones; C M Roifman; A M Griffiths; P Sherman
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

5.  Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy.

Authors:  M Raithel; M Matek; H W Baenkler; W Jorde; E G Hahn
Journal:  Int Arch Allergy Immunol       Date:  1995-10       Impact factor: 2.749

Review 6.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 7.  Role of intestinal mast cells in modulating gastrointestinal pathophysiology.

Authors:  G R Stenton; H Vliagoftis; A D Befus
Journal:  Ann Allergy Asthma Immunol       Date:  1998-07       Impact factor: 6.347
  7 in total
  7 in total

1.  Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis.

Authors:  Zhongcheng Shi; Robert S Fultz; Melinda A Engevik; Chunxu Gao; Anne Hall; Angela Major; Yuko Mori-Akiyama; James Versalovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-21       Impact factor: 4.052

2.  Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases.

Authors:  Alexander F Hagel; Christian M Layritz; Wolfgang H Hagel; Hans-Jürgen Hagel; Edith Hagel; Wolfgang Dauth; Jürgen Kressel; Tanja Regnet; Andreas Rosenberg; Markus F Neurath; Gerhard J Molderings; Martin Raithel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-11       Impact factor: 3.000

3.  Excretion of urinary histamine and N-tele methylhistamine in patients with gastrointestinal food allergy compared to non-allergic controls during an unrestricted diet and a hypoallergenic diet.

Authors:  Martin Raithel; Alexander Hagel; Heinz Albrecht; Yurdaguel Zopf; Andreas Naegel; Hanns-Wolf Baenkler; Fred Buchwald; Hans-Wolfgang Schultis; Juergen Kressel; Eckhart Georg Hahn; Peter Konturek
Journal:  BMC Gastroenterol       Date:  2015-04-01       Impact factor: 3.067

Review 4.  Histamine: an undercover agent in multiple rare diseases?

Authors:  Almudena Pino-Ángeles; Armando Reyes-Palomares; Esther Melgarejo; Francisca Sánchez-Jiménez
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

5.  Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis.

Authors:  J B Wechsler; A Szabo; C L Hsu; R A Krier-Burris; H A Schroeder; M Y Wang; R G Carter; T E Velez; L M Aguiniga; J B Brown; M L Miller; B K Wershil; T A Barrett; P J Bryce
Journal:  Mucosal Immunol       Date:  2018-01-24       Impact factor: 7.313

6.  Ex vivo study of human visceral nociceptors.

Authors:  Cian McGuire; George Boundouki; James R F Hockley; David Reed; Vincent Cibert-Goton; Madusha Peiris; Victor Kung; John Broad; Qasim Aziz; Christopher Chan; Shafi Ahmed; Mohamed A Thaha; Gareth J Sanger; L Ashley Blackshaw; Charles H Knowles; David C Bulmer
Journal:  Gut       Date:  2016-09-21       Impact factor: 23.059

7.  Loratadine Alleviates Advanced Glycation End Product-Induced Activation of NLRP3 Inflammasome in Human Chondrocytes.

Authors:  Feng Gao; Shanyong Zhang
Journal:  Drug Des Devel Ther       Date:  2020-07-21       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.